Tirzepatide, a weekly GLP-1 and GIP drug, produced weight loss of up to 17.8% after 72 weeks. Semaglutide, a weekly GLP-1 ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

Comedian Nikki Glaser, host of the 2025 Golden Globe Awards ceremony, dove right in at the start of her opening monologue: ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

A study in pigs has shown that the active ingredient in Ozempic and Wegovy directly boosts heart health, in addition to the ...

Shaelyn Weaver, after struggling with weight issues due to PCOS and pre-diabetes, embarked on a significant weight loss ...

The medications are so common now, two-thirds of the clinic’s calls for insurance pre-authorizations are for the big three: ...

Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?

A new study finds semaglutide is linked to an increased risk of vision loss associated with a rare eye condition, but cases remain rare. Here's what experts want you to know.

GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...

They initially lost 40 pounds effortlessly, but now the weight is returning and so are the craving for sweets.

Exercise includes cardio and strength training, which together support heart health, healthy blood sugar levels, and weight ...